Word

IMGLYSTA

Status

Pending

Status Code

688

Status Date

Tuesday, January 23, 2024

Serial Number

97822927

Mark Type

4000

Filing Date

Friday, March 3, 2023

Published for Opposition

Tuesday, November 28, 2023

Trademark Owner History

Ultragenyx Pharmaceutical Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery

44 Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders

42 Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders

Trademark Events

Jan 23, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 28, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 28, 2023

Published For Opposition

Nov 8, 2023

Notification Of Notice Of Publication E-Mailed

Oct 25, 2023

Approved For Pub - Principal Register

Oct 25, 2023

Teas/Email Correspondence Entered

Oct 24, 2023

Correspondence Received In Law Office

Oct 24, 2023

Teas Response To Office Action Received

Sep 24, 2023

Notification Of Non-Final Action E-Mailed

Sep 24, 2023

Non-Final Action E-Mailed

Sep 24, 2023

Non-Final Action Written

Sep 21, 2023

Assigned To Examiner

Mar 24, 2023

New Application Office Supplied Data Entered

Mar 7, 2023

New Application Entered